The US Supreme Court on Monday rejected a series of appeals from several of the nation's largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. https://t.co/R8kiPkRZro ...